Riskpilot← Back to searchSign inGet full accessOPPSALKLINIKKEN AS
ASActiveOrg 999311172John G. Mattesons Vei 4, 0687 OsloPhysiotherapy activities · NACE 8695Est. 20130 employeeswww.oppsalklinikken.no
Revenue 2025
NOK 3M
-2% vs 2024
EBITDA margin
2.6%
-32% vs 2024
Equity ratio
83.7%
Financial strength
Net profit 2025
NOK 4K
-90% vs 2024
| Revenue | NOK 3M | -2% |
| EBITDA | NOK 79K | -32% |
| Net profit | NOK 4K | -90% |
| Total assets | NOK 758K | -12% |
| Equity | NOK 634K | +1% |
| Employees | 0 | — |
Legal name
OPPSALKLINIKKEN AS
Org number
999311172
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
3. januar 2013
Share capital
NOK 300 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Salg av tjenester og produkter innen fysioterapi, andre terapiformer og trening samt alt som naturlig hører sammen med dette. Delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
John G. Mattesons Vei 4, 0687 Oslo
Website
www.oppsalklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 871 | 2 955 | 3 167 | 3 056 | 2 981 |
| Staff expenses | −54 | −49 | −61 | −49 | −31 |
| EBITDA | 36 | 15 | 134 | 116 | 79 |
| Depreciation & amort. | −28 | −45 | −61 | −69 | −77 |
| EBIT | 7 | −30 | 73 | 47 | 2 |
| Net financials | 0 | 2 | 7 | 11 | 8 |
| Profit before tax | 8 | −28 | 80 | 58 | 10 |
| Tax | −0 | −3 | 9 | 14 | 6 |
| Net profit | 8 | −25 | 71 | 44 | 4 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 857 | 783 | 836 | 862 | 758 |
| Equity | 540 | 516 | 586 | 630 | 634 |
| Long-term debt | 3 | 3 | 3 | 0 | 0 |
| Short-term debt | 314 | 265 | 247 | 232 | 124 |
| Total debt | 316 | 267 | 250 | 232 | 124 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20212025
Equity ratio
83.7%
This company
38.2%
Market median
+119% vs market
20212025
Return on equity
0.7%
This company
18.4%
Market median
-96% vs market
20212025
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20212025
Asset turnover
3.93×
This company
1.12×
Market median
+251% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
MH Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OPPSALKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Eriksen-Hagenes | Chief Executive Officer | 0 companies |
| Morten Hagenes | Chief Executive Officer | 0 companies |
| Vegard Ølstørn | Board of Directors | 0 companies |
| Monica Nordløkken | Chairman | 0 companies |
| Gry Brusletto | Board of Directors | 0 companies |
| Lars Østbø | Board of Directors | 0 companies |